{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:59:30Z","timestamp":1774965570997,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science Foundation","award":["NSF-2200052"],"award-info":[{"award-number":["NSF-2200052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10822-023-00546-w","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T01:05:16Z","timestamp":1706058316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface"],"prefix":"10.1007","volume":"38","author":[{"given":"Maria","family":"Lazou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arijit","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9685-6177","authenticated-orcid":false,"given":"Diane","family":"Joseph-McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"546_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","volume":"78","author":"M Nicola","year":"2020","unstructured":"Nicola M, Alsafi Z, Sohrabi C et al (2020) The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 78:185\u2013193. https:\/\/doi.org\/10.1016\/j.ijsu.2020.04.018","journal-title":"Int J Surg"},{"key":"546_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey WT, Carabelli AM, Jackson B et al (2021) SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol 19:409\u2013424. https:\/\/doi.org\/10.1038\/s41579-021-00573-0","journal-title":"Nat Rev Microbiol"},{"key":"546_CR3","doi-asserted-by":"publisher","first-page":"e0250780","DOI":"10.1371\/journal.pone.0250780","volume":"16","author":"D Van Egeren","year":"2021","unstructured":"Van Egeren D, Novokhodko A, Stoddard M et al (2021) Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. PLoS ONE 16:e0250780. https:\/\/doi.org\/10.1371\/journal.pone.0250780","journal-title":"PLoS ONE"},{"key":"546_CR4","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.2174\/1568026623666221019110334","volume":"22","author":"A Gaurav","year":"2022","unstructured":"Gaurav A, Agrawal N, Al-Nema M, Gautam V (2022) Computational approaches in the discovery and development of therapeutic and prophylactic agents for viral diseases. Curr Top Med Chem 22:2190\u20132206. https:\/\/doi.org\/10.2174\/1568026623666221019110334","journal-title":"Curr Top Med Chem"},{"key":"546_CR5","doi-asserted-by":"publisher","first-page":"e170122200314","DOI":"10.2174\/1570163819666220117161308","volume":"19","author":"BM Sahoo","year":"2022","unstructured":"Sahoo BM, Bhattamisra SK, Das S et al (2022) Computational approach to combat COVID-19 infection: emerging tools for accelerating drug research. Curr Drug Discov Technol 19:e170122200314. https:\/\/doi.org\/10.2174\/1570163819666220117161308","journal-title":"Curr Drug Discov Technol"},{"key":"546_CR6","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.2174\/1568026623666221103091658","volume":"22","author":"A Shanmugam","year":"2022","unstructured":"Shanmugam A, Venkattappan A, Gromiha MM (2022) Structure based drug designing approaches in SARS-CoV-2 spike inhibitor design. Curr Top Med Chem 22:2396\u20132409. https:\/\/doi.org\/10.2174\/1568026623666221103091658","journal-title":"Curr Top Med Chem"},{"key":"546_CR7","doi-asserted-by":"publisher","first-page":"105235","DOI":"10.1016\/j.compbiomed.2022.105235","volume":"143","author":"A Mehmood","year":"2022","unstructured":"Mehmood A, Nawab S, Wang Y et al (2022) Discovering potent inhibitors against the Mpro of the SARS-CoV-2: a medicinal chemistry approach. Comput Biol Med 143:105235. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105235","journal-title":"Comput Biol Med"},{"key":"546_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2245042","author":"A Mehmood","year":"2023","unstructured":"Mehmood A, Nawab S, Jia G et al (2023) Supervised screening of Tecovirimat-like compounds as potential inhibitors for the monkeypox virus E8L protein. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2245042","journal-title":"J Biomol Struct Dyn"},{"key":"546_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J et al (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581:215\u2013220. https:\/\/doi.org\/10.1038\/s41586-020-2180-5","journal-title":"Nature"},{"key":"546_CR10","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang J, Wan Y, Luo C et al (2020) Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci U S A 117:11727\u201311734. https:\/\/doi.org\/10.1073\/pnas.2003138117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"546_CR11","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/cells9112343","volume":"9","author":"AC Papageorgiou","year":"2020","unstructured":"Papageorgiou AC, Mohsin I (2020) The SARS-CoV-2 spike glycoprotein as a drug and vaccine target: structural insights into its complexes with ACE2 and antibodies. Cells 9:2343. https:\/\/doi.org\/10.3390\/cells9112343","journal-title":"Cells"},{"key":"546_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13578-020-00404-4","volume":"10","author":"K-S Yuen","year":"2020","unstructured":"Yuen K-S, Ye Z-W, Fung S-Y et al (2020) SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci 10:40. https:\/\/doi.org\/10.1186\/s13578-020-00404-4","journal-title":"Cell Biosci"},{"key":"546_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.29252\/rbmb.9.1.97","volume":"9","author":"G Mostafa-Hedeab","year":"2020","unstructured":"Mostafa-Hedeab G et al (2020) ACE2 as drug target of COVID-19 virus treatment, simplified updated review. rbmb.net 9:97\u2013105. https:\/\/doi.org\/10.29252\/rbmb.9.1.97","journal-title":"rbmb.net"},{"key":"546_CR14","doi-asserted-by":"publisher","first-page":"198154","DOI":"10.1016\/j.virusres.2020.198154","volume":"289","author":"HR Rangel","year":"2020","unstructured":"Rangel HR, Ortega JT, Maksoud S et al (2020) SARS-CoV-2 host tropism: an in silico analysis of the main cellular factors. Virus Res 289:198154. https:\/\/doi.org\/10.1016\/j.virusres.2020.198154","journal-title":"Virus Res"},{"key":"546_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jinf.2020.09.004","volume":"82","author":"AA Elfiky","year":"2021","unstructured":"Elfiky AA, Ibrahim IM, Ismail AM, Elshemey WM (2021) A possible role for GRP78 in cross vaccination against COVID-19. J Infect 82:282\u2013327. https:\/\/doi.org\/10.1016\/j.jinf.2020.09.004","journal-title":"J Infect"},{"key":"546_CR16","doi-asserted-by":"publisher","first-page":"100759","DOI":"10.1016\/j.jbc.2021.100759","volume":"296","author":"AJ Carlos","year":"2021","unstructured":"Carlos AJ, Ha DP, Yeh D-W et al (2021) The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. J Biol Chem 296:100759. https:\/\/doi.org\/10.1016\/j.jbc.2021.100759","journal-title":"J Biol Chem"},{"key":"546_CR17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.str.2015.10.012","volume":"23","author":"J Yang","year":"2015","unstructured":"Yang J, Nune M, Zong Y et al (2015) Close and allosteric opening of the polypeptide-binding site in a human Hsp70 chaperone BiP. Structure 23:2191\u20132203. https:\/\/doi.org\/10.1016\/j.str.2015.10.012","journal-title":"Structure"},{"key":"546_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","volume":"80","author":"IM Ibrahim","year":"2020","unstructured":"Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky AA (2020) COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect 80:554\u2013562. https:\/\/doi.org\/10.1016\/j.jinf.2020.02.026","journal-title":"J Infect"},{"key":"546_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1021\/ja026939x","volume":"125","author":"C Dominguez","year":"2003","unstructured":"Dominguez C, Boelens R, Bonvin AMJJ (2003) HADDOCK: a protein\u2212protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125:1731\u20131737. https:\/\/doi.org\/10.1021\/ja026939x","journal-title":"J Am Chem Soc"},{"key":"546_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","volume":"428","author":"GCP van Zundert","year":"2016","unstructured":"van Zundert GCP, Rodrigues JPGLM, Trellet M et al (2016) The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol 428:720\u2013725. https:\/\/doi.org\/10.1016\/j.jmb.2015.09.014","journal-title":"J Mol Biol"},{"key":"546_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41467-017-01310-z","volume":"8","author":"J Yang","year":"2017","unstructured":"Yang J, Zong Y, Su J et al (2017) Conformation transitions of the polypeptide-binding pocket support an active substrate release from Hsp70s. Nat Commun 8:1201. https:\/\/doi.org\/10.1038\/s41467-017-01310-z","journal-title":"Nat Commun"},{"key":"546_CR22","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.bmcl.2008.01.060","volume":"18","author":"Y Yoneda","year":"2008","unstructured":"Yoneda Y, Steiniger SCJ, \u010capkov\u00e1 K et al (2008) A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy. Bioorg Med Chem Lett 18:1632\u20131636. https:\/\/doi.org\/10.1016\/j.bmcl.2008.01.060","journal-title":"Bioorg Med Chem Lett"},{"key":"546_CR23","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1021\/bi060264j","volume":"45","author":"Y Kim","year":"2006","unstructured":"Kim Y, Lillo AM, Steiniger SCJ et al (2006) Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. Biochemistry 45:9434\u20139444. https:\/\/doi.org\/10.1021\/bi060264j","journal-title":"Biochemistry"},{"key":"546_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp036","author":"R Brenke","year":"2009","unstructured":"Brenke R, Kozakov D, Chuang GY, Beglov D, Hall D, Landon MR, Mattos C, Vajda S (2009) Fragment-based identification of druggable \u201chot spots\u201d of proteins using Fourier domain correlation techniques. Bioinformatics. https:\/\/doi.org\/10.1093\/bioinformatics\/btp036","journal-title":"Bioinformatics"},{"key":"546_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nprot.2015.043","volume":"10","author":"D Kozakov","year":"2015","unstructured":"Kozakov D, Grove LE, Hall DR et al (2015) The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat Protoc 10:733\u2013755. https:\/\/doi.org\/10.1038\/nprot.2015.043","journal-title":"Nat Protoc"},{"key":"546_CR26","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1021\/acs.jmedchem.5b00586","volume":"58","author":"D Kozakov","year":"2015","unstructured":"Kozakov D, Hall DR, Napoleon RL et al (2015) New frontiers in druggability. J Med Chem 58:9063\u20139088. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00586","journal-title":"J Med Chem"},{"key":"546_CR27","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring\u20141: method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"546_CR28","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"546_CR29","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring\u20142: enrichment factors in database screening. J Med Chem 47:1750\u20131759. https:\/\/doi.org\/10.1021\/jm030644s","journal-title":"J Med Chem"},{"key":"546_CR30","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ (2015) ZINC 15\u2014ligand discovery for everyone. J Chem Inf Model 55:2324\u20132337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559","journal-title":"J Chem Inf Model"},{"key":"546_CR31","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100\u2013D1107. https:\/\/doi.org\/10.1093\/nar\/gkr777","journal-title":"Nucleic Acids Res"},{"key":"546_CR32","unstructured":"Schr\u00f6dinger release 2022\u20133: QikProp (2021) Schr\u00f6dinger, LLC, New York"},{"key":"546_CR33","volume-title":"Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization","author":"L Di","year":"2016","unstructured":"Di L, Kerns EH (2016) Drug-like properties: concepts, structure design and methods from ADME to toxicity optimization, 2nd edn. Academic Press","edition":"2"},{"key":"546_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jmgm.2010.05.008","volume":"29","author":"J Duan","year":"2010","unstructured":"Duan J, Dixon SL, Lowrie JF, Sherman W (2010) Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods. J Mol Graph Model 29:157\u2013170. https:\/\/doi.org\/10.1016\/j.jmgm.2010.05.008","journal-title":"J Mol Graph Model"},{"key":"546_CR35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1021\/ci100062n","volume":"50","author":"M Sastry","year":"2010","unstructured":"Sastry M, Lowrie JF, Dixon SL, Sherman W (2010) Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J Chem Inf Model 50:771\u2013784. https:\/\/doi.org\/10.1021\/ci100062n","journal-title":"J Chem Inf Model"},{"key":"546_CR36","first-page":"865","volume":"26","author":"S Weston","year":"2020","unstructured":"Weston S, Coleman CM, Haupt R et al (2020) Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo. Microbiology 26:865","journal-title":"Microbiology"},{"key":"546_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-008055232-3.61066-9","volume-title":"xPharm: the comprehensive pharmacology reference","author":"SJ Enna","year":"2008","unstructured":"MARSH W (2007) Tricyclic antidepressants. In: Enna SJ, Bylund DB, Elsevier Science (FIRM) (eds) xPharm: the comprehensive pharmacology reference. Amsterdam: Elsevier, pp 1\u20133. https:\/\/doi.org\/10.1016\/B978-008055232-3.61066-9"},{"issue":"11","key":"546_CR38","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.14670\/HH-23.1409","volume":"23","author":"QJ Quinones","year":"2008","unstructured":"Quinones QJ et al (2008) GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. Histol histopathol 23(11):1409\u20131416. https:\/\/doi.org\/10.14670\/HH-23.1409","journal-title":"Histol histopathol"},{"key":"546_CR39","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1038\/s41598-018-22905-6","volume":"8","author":"KRDSNS Gurusinghe","year":"2018","unstructured":"Gurusinghe KRDSNS, Mishra A, Mishra S (2018) Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: molecular dynamics studies. Sci Rep 8:5487. https:\/\/doi.org\/10.1038\/s41598-018-22905-6","journal-title":"Sci Rep"},{"key":"546_CR40","unstructured":"Halford B (2022) How Pfizer scientists transformed an old drug lead into a COVID-19 antiviral Behind the scenes of the medicinal chemistry campaign that led to the pill Paxlovid"},{"key":"546_CR41","doi-asserted-by":"publisher","first-page":"106708","DOI":"10.1016\/j.ijantimicag.2022.106708","volume":"61","author":"D Focosi","year":"2023","unstructured":"Focosi D, McConnell S, Shoham S et al (2023) Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics. Int J Antimicrob Agents 61:106708. https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106708","journal-title":"Int J Antimicrob Agents"},{"key":"546_CR42","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq E, Li G (2016) Approved antiviral drugs over the past 50 years. Clin Microbiol Rev 29:695\u2013747. https:\/\/doi.org\/10.1128\/CMR.00102-15","journal-title":"Clin Microbiol Rev"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-023-00546-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-023-00546-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-023-00546-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T12:14:54Z","timestamp":1732623294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-023-00546-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1007\/s10822-023-00546-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"10 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"6"}}